Advanced or metastatic MTAP-deleted solid tumors

Clinical trials for Advanced or metastatic MTAP-deleted solid tumors explained in plain language.

Never miss a new study

Get alerted when new Advanced or metastatic MTAP-deleted solid tumors trials appear

Sign up with your email to follow new studies for Advanced or metastatic MTAP-deleted solid tumors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

New pill shows promise for Hard-to-Treat cancers in early trial

Disease control Stopped early

This early-phase study tested a new oral drug called BG-89894 (SYH2039) in 29 adults with advanced solid tumors that have a specific genetic deletion (MTAP). The main goals were to check safety, find the right dose, and see if the drug shows any signs of shrinking tumors. The tri…

Matched conditions: ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS

Phase 1 • Sponsor: BeOne Medicines • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

Advanced or metastatic MTAP-deleted solid tumors

Get alerted when new Advanced or metastatic MTAP-deleted solid tumors trials appear

New pill shows promise for Hard-to-Treat cancers in early trial